 |
|
|
|
|
New Weight-Loss Drug Shows Promise in Early Study
|
| | | | Related Healthscout Videos | |
|
Page: << Prev | 1 | 2 | 3 But he said the new drug, if approved, won't be for everyone. "This is not going to be a class of drugs that people take because they want to look good on vacation" and lose 10 pounds or so, Smith said.
"I think this class of drugs, should it make it to market, is going to need to be reserved for people who have complications related to their obesity, such as type 2 diabetes, high blood pressure or severe osteoarthritis," Smith said. In general, he added, taranabant would be best for those with a body mass index of 30 or higher (classified as obese), or those with a BMI of 27, considered overweight, but with complications.
More information
Text Continues Below
To learn more about obesity, visit the Obesity Society.
Page: << Prev | 1 | 2 | 3
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 1/8/2008
|
|
SOURCES: Steven R. Smith, M.D., head, public affairs committee, the Obesity Society, and professor and assistant to the associate director for clinical research, Pennington Biomedical ResearchCenter, Baton Rouge, La.; Steven Heymsfield, M.D., global director, scientific affairs, obesity, Merck Research Laboratories, Rahway, N.J.; January 2008, Cell Metabolism
|
.gif)
